IRIS
RIZZOLI, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.604
AS - Asia 6.661
EU - Europa 4.364
SA - Sud America 830
AF - Africa 313
Continente sconosciuto - Info sul continente non disponibili 113
OC - Oceania 2
Totale 19.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.339
SG - Singapore 2.380
CN - Cina 2.024
VN - Vietnam 967
IE - Irlanda 763
SE - Svezia 758
FI - Finlandia 741
BR - Brasile 610
UA - Ucraina 566
DE - Germania 551
HK - Hong Kong 440
TR - Turchia 276
IT - Italia 229
FR - Francia 205
ZA - Sudafrica 200
BD - Bangladesh 184
NL - Olanda 183
CA - Canada 167
GB - Regno Unito 127
IN - India 91
AR - Argentina 72
RU - Federazione Russa 54
EC - Ecuador 51
MX - Messico 43
CI - Costa d'Avorio 42
CO - Colombia 34
IQ - Iraq 33
BE - Belgio 32
JP - Giappone 32
RO - Romania 25
ID - Indonesia 24
PH - Filippine 24
PL - Polonia 24
ES - Italia 23
IR - Iran 22
TH - Thailandia 21
PK - Pakistan 19
VE - Venezuela 19
TW - Taiwan 18
MA - Marocco 16
CZ - Repubblica Ceca 15
EU - Europa 15
UZ - Uzbekistan 14
LT - Lituania 13
UY - Uruguay 13
SA - Arabia Saudita 12
CR - Costa Rica 11
JM - Giamaica 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
CL - Cile 9
KE - Kenya 9
PY - Paraguay 9
JO - Giordania 8
KR - Corea 8
MY - Malesia 8
PE - Perù 8
DO - Repubblica Dominicana 7
EG - Egitto 7
IL - Israele 7
LV - Lettonia 7
NP - Nepal 7
DZ - Algeria 6
HN - Honduras 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
EE - Estonia 5
ET - Etiopia 5
KZ - Kazakistan 5
NI - Nicaragua 5
SC - Seychelles 5
BO - Bolivia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
HU - Ungheria 3
LK - Sri Lanka 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
AO - Angola 2
CY - Cipro 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 19.768
Salva come PNG Salva come JPEG
Città #
Singapore 1.163
Ashburn 818
Dublin 763
Chandler 712
Jacksonville 655
San Jose 634
Santa Clara 468
Beijing 459
Hong Kong 406
Ho Chi Minh City 281
Council Bluffs 278
Dearborn 253
Nanjing 238
Izmir 227
Boardman 226
Dallas 222
Hanoi 211
Johannesburg 191
San Mateo 186
Princeton 160
Los Angeles 159
Ann Arbor 141
Lauterbourg 141
Toronto 109
New York 104
Shanghai 104
Wilmington 98
Shenyang 88
Nanchang 82
Helsinki 76
Kunming 74
Hefei 73
Munich 70
Buffalo 65
Hebei 65
Düsseldorf 63
Jinan 63
São Paulo 56
Parma 50
Des Moines 49
Da Nang 47
Haiphong 45
Abidjan 42
Woodbridge 40
Changsha 39
Marseille 38
Guangzhou 37
Tianjin 37
Jiaxing 35
Bremen 33
Moscow 33
Brussels 32
Columbus 31
Seattle 31
Pune 30
Atlanta 28
Houston 26
Kocaeli 26
Leawood 25
Stockholm 24
Turku 24
Zhengzhou 24
Frankfurt am Main 23
Montreal 23
Tokyo 23
Brooklyn 22
Grafing 22
San Francisco 22
Warsaw 22
Hải Dương 21
Hangzhou 20
Augusta 19
Norwalk 19
London 18
Phoenix 18
Guayaquil 17
Quito 17
Rome 17
Ningbo 16
Orem 16
Rio de Janeiro 16
Amsterdam 15
Focsani 15
Milan 15
North Bergen 15
Bologna 14
Chicago 14
Mestre 14
Boston 13
Lanzhou 13
Monmouth Junction 13
Nuremberg 13
Pittsburgh 13
Tashkent 13
Ardabil 12
Brasília 12
Chongqing 12
Denver 12
Fremont 12
Haikou 12
Totale 11.631
Salva come PNG Salva come JPEG
Nome #
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 271
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 240
Are the Myeloma bone microevironment cells tumoral or not? 234
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 213
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 201
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 197
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 196
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 191
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 190
Amifostine (WR-2721) selective protection against melphalan genotoxicity 189
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 184
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 183
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 182
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 180
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 177
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 174
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 172
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. 170
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 169
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 167
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 167
Angiopoietins expression by human myeloma cells 164
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 164
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 162
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 162
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment 161
Angiogenic switch in multiple myeloma patients 158
Bleomycin Genotoxicity and Amifostine (WR-2721) Cell Protection in Normal Leukocytes versus K562 Tumoral Cells 158
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 158
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 157
Angiogenic properties of human myeloma cells: role of angiopoietin system 156
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 156
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 156
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 155
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 155
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 155
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 155
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 153
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 153
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 151
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 151
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 148
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 147
Alterations of microenvironment in multiple myeloma patients: Interactions between myeloma cells and osteoprogenitor cells 147
Do human myeloma cells directly produce basic FGF? 146
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 145
EPIRUBICIN PLUS G-CSF ELICITED PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IS SIGNIFICANTLY ENHANCED BY AMIFOSTINE 143
Angiopoietin-1 and myeloma-induced angiogenesis 143
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 143
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 142
Angiogenic switch in multiple myeloma 141
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 140
Macrophage inflammatory protein (MIP)-3 alpha/CCL20 and its receptor CCR6 are overexpressed in the bone microenvironment and involved in osteoclast formation in multiple myeloma patients. 140
Expression and role of chemokine receptor CXCR3 in multiple myeloma 138
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 137
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 136
Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. 134
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 134
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets 133
Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. 131
Gamma-rays from Mössbauer sources: a low-dose approach to cancer therapy 130
Arsenic trioxide in hematological malignancies: The new discovery of an ancient drug 130
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with Multiple Myeloma bone disease 129
Autotransplantation in acute leukemia. 129
RANKL is critically involved in the physiopathology of multiple myeloma 128
Mossbauer analysis of bone marrow before and after purging with Asta-z 7557 127
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 126
DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status. 126
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 123
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 122
Osteopontin is produced by human multiple myeloma cells 122
Effects of Mössbauer radiation on bone marrow cultures 122
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 121
Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow. 121
Beta-catenin depended and independent effects induced by myeloma cells in human and murine osteoblasts and osteoblast progenitors. 120
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 119
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 119
Impact of XIAP protein levels on the survival of myeloma cells 118
DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay 117
HUMAN MYELOMA CELLS EXPRESS THE BONE REGULATING GENE RUNX2/CBFA1 AND PRODUCE OSTEOPONTIN THAT IT IS INVOLVED IN MYELOMA INDUCED ANGIOGENESIS 116
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group 116
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 112
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens 112
Multiple myeloma patient with unusual extramedullary involvement 112
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 110
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 110
The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients. 110
Human myeloma cells produce angiopoietin-1: potential relationship with myeloma-induced angiogenesis 109
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 109
IL-7 is produced by myeloma cells in presence of IL-6 108
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide 108
Role of tumor necrosis factor-related activation-induced cytokine (TRANCE) in multiple myeloma 107
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. 107
Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value? 106
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients 106
Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein 104
MYELOMA CELLS BLOCK RUNX2/CBFA1 ACTIVITY IN HUMAN BONE MARROW OSTEOBLAST PROGENITORS AND INHIBIT OSTEOBLAST FORMATION AND DIFFERENTIATION 103
Expression of pro-angiogenetic factors by myeloma cells: role of the angiopoietin system 103
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. 102
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells 102
Totale 14.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022766 0 0 0 56 16 31 94 137 35 85 80 232
2022/20232.743 357 295 171 193 250 284 53 151 891 11 74 13
2023/2024866 40 105 21 16 75 196 82 89 22 41 69 110
2024/20252.899 52 178 198 202 313 284 47 93 419 283 242 588
2025/20266.673 576 589 763 665 1.006 402 688 208 904 472 240 160
2026/20271.165 174 349 302 340 0 0 0 0 0 0 0 0
Totale 19.887